ABVXAbivax SA American Depositary Shares
114.95USDMkt Cap: 10.03B $P/E: —3d ago
ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases.…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap10.03B $
Enterprise Value8.66B $
Revenue (TTM)4.92M $
Gross Profit4.92M $
Net Income (TTM)-336.10M $
Revenue/Share0.0670 USD
Last Price114.95 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees80
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-36.54
PEG—
EV/EBITDA-34.08
EV/Revenue1759.59
P/S2038.58
P/B18.15
EPS (TTM)-5.38
EPS (Forward)-3.15
52W Range
114.508% of range120.25
52W High120.25 USD
52W Low114.50 USD
Profitability
Gross Margin100.00%
Oper. Margin-4183.70%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-73.84%
ROA-57.52%
Growth
Revenue Growth35.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-161.13M $
CapEx (TTM)142.00K $
FCF Margin-2326.66%
FCF Yield-1.14%
Net Debt-457.34M $
Net Debt/EBITDA1.80
Balance Sheet
Debt/Equity0.00
Current Ratio8.25
Quick Ratio8.07
Book Value/Sh6.332 USD
Cash/Share6.199 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)165.91 USD
Upside (mean)+44.3%
Target Range142.00 USD – 187.00 USD
$142.00+44.3% to mean$187.00
# Analysts11
Ownership
Shares Out.87.25M
Float70.14M
Insiders0.00%
Institutions76.81%
Short Interest
Short Ratio3.0d
Short % Float6.03%
Short % Out.5.96%
Shares Short5.19M
Short (prev mo.)4.33M
Technical
SMA 50121.83 (-5.6%)
SMA 200118.95 (-3.4%)
Beta-0.23
S&P 52W Chg19.18%
Avg Vol (30d)974.30K
Avg Vol (10d)766.58K
Technical Indicators
RSI (14)37.9
MACD-2.0572
MACD Signal-0.7485
MACD Hist.-1.3088
BB Upper132.03 USD
BB Middle123.51 USD
BB Lower114.99 USD
BB Width13.80%
ATR (14)5.022 USD
Vol Ratio (20d)1.11x